These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Iproniazid in psychiatry]. ARRUDA E, de ARRUDA RA, CASTANHEIRA JA. Hospital (Rio J); 1959 Aug; 56():265-79. PubMed ID: 13794522 [No Abstract] [Full Text] [Related]
3. [Iproniazid in psychiatry]. KORENKE HD. Berl Med; 1961 Nov 10; 12():487-91. PubMed ID: 14458406 [No Abstract] [Full Text] [Related]
4. Twenty month study of iproniazid therapy. JOEL SW. Dis Nerv Syst; 1959 Nov 10; 20():521-4. PubMed ID: 14407353 [No Abstract] [Full Text] [Related]
5. The use of marsilid in the treatment of mental disorders resistive to previous therapy. BREITNER C. Ariz Med; 1959 Nov 10; 16():732-5. PubMed ID: 13804145 [No Abstract] [Full Text] [Related]
6. [Clinical observations on the use of iproniazid in tuberculous psychopaths]. AGRESTI E. Riv Patol Nerv Ment; 1959 Nov 10; 80():383-5. PubMed ID: 13792067 [No Abstract] [Full Text] [Related]
7. [Iproniazid, a monoamino oxidase inhibitor. Its use in psychiatry and cardiology]. SOLIGNAC H. Rev Prat; 1960 Mar 01; 10():773-81. PubMed ID: 13832608 [No Abstract] [Full Text] [Related]
8. [Clinical effects of Marsilid and its EEG evaluation]. KRONBERGEROVA J, JANIK A. Act Nerv Super (Praha); 1962 Mar 01; 4():229. PubMed ID: 14459822 [No Abstract] [Full Text] [Related]
9. [Contribution to the use in psychiatry of isonicotinyl-isopropyl-hydrazine-phosphate]. PASOLINI F. Rass Med Sarda; 1959 Mar 01; 61():615-22. PubMed ID: 14430708 [No Abstract] [Full Text] [Related]
10. Nialamide in the private practice of psychiatry. KLINE NS. Dis Nerv Syst; 1959 Oct 01; 20():482-8. PubMed ID: 14409888 [No Abstract] [Full Text] [Related]
11. [Iproniazid in psychiatric therapeutics]. INSUA JA, BERARD E. Presse Med (1893); 1959 Aug 01; 67():1458-9. PubMed ID: 13852909 [No Abstract] [Full Text] [Related]
12. [Clinical experiences with iproniazid and additional monoamine oxidase inhibitors with analogous effects]. VOELKEL A. Psychiatr Neurol (Basel); 1960 Jul 01; 140():83-8. PubMed ID: 13781777 [No Abstract] [Full Text] [Related]
13. [Clinical, electroencephalographic and psychometric research on iproniazid (marsilid) in depressive diseases]. MARTINI F, ANGELER F, BIAGIOTTI F. Riv Patol Nerv Ment; 1959 Jul 01; 80():370-1. PubMed ID: 14421822 [No Abstract] [Full Text] [Related]
14. [Effect of marsilid in psychiatric disorders]. MOUSSONG-KOVACS E. Orv Hetil; 1960 Aug 14; 101():1180-2. PubMed ID: 14424789 [No Abstract] [Full Text] [Related]
15. [Clinical results of treatment with "IIH" in cases of essential and symptomatic depressive psychopathy and psychoses]. BELUFFI M. Gazz Med Ital; 1959 Aug 14; 118():307-14. PubMed ID: 13798674 [No Abstract] [Full Text] [Related]
16. [Therapy of psychic diseases with iproniazid (marsilid)]. SCHAEPPERLE O. Nervenarzt; 1959 Dec 20; 30():557-61. PubMed ID: 14442364 [No Abstract] [Full Text] [Related]
17. The multifactorial approach in psychiatry. HOFF H. J Neuropsychiatr; 1960 Apr 20; 1():173-81. PubMed ID: 14402360 [No Abstract] [Full Text] [Related]
18. [Pathophysiological principles in active therapy in psychiatry]. PIATKOWSKI F. Neurol Neurochir Psychiatr Pol; 1953 Apr 20; 3(2):161-73. PubMed ID: 13072790 [No Abstract] [Full Text] [Related]
19. The new pharmacologic attack in psychiatry. FABING HD. Int Rec Med Gen Pract Clin; 1956 Apr 20; 169(4):177-83. PubMed ID: 13318730 [No Abstract] [Full Text] [Related]